Skip to content
Screener

Mobileye Global Inc. MBLY All Other Segments — Research And Development Expense

Other segment segments

Mobileye
$152M-29.3%

Similar metrics at other companies

MapLight Therapeutics, Inc. logo
MPLTAll Other Segments — Research And Development Expense
$933K+22.6%
FTE
FTEKAll Other Segments — Research And Development Expense
$524K-8.1%
Beam Therapeutics logo
BEAMExternal Research And Development Expenses — Research And Development Expense
$30.08M-12.6%
Disc Medicine logo
IRONOther Research — Research And Development Expense
$2.17M+18.2%
Gentherm logo
THRMAutomotive Segments — Research And Development Expense
$19.84M+11.3%
Corvex logo
MOVESegment Reporting — Research And Development Expense
$1.2M

Other financials

Income statement

See full
Revenue$508.0M+0.4%
Gross profit$235.0M-6.7%
Operating income-$30.0M+59.5%
Net income-$21.0M+68.7%
EPS (diluted)-$0.03+62.5%

Balance sheet

See full
Cash & equivalents$1.3B-23.3%
Total debt$62.0M+24.0%
Total equity$8.2B-32.0%
Total assets$8.8B-29.7%

Cash flow

See full
Operating cash flow$135.0M-36.6%
CapEx$21.0M+50.0%
Free cash flow$114.0M-42.7%

Valuation

See full
Market cap$2.13B-81.2%
P/S1.1×-4.8×

Profitability

See full
Gross margin47.4%-1.4pp
Operating margin-207.1%+84.3pp
Net margin-201.5%+90.2pp
FCF margin19.2%-11.4pp

Returns & leverage

See full
Return on equity-40.1%+178pp
Debt / equity0.0×
Current ratio4.6×-2.3×

Where this comes from

Reported directly by Mobileye Global Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The source filing: Mobileye Global Inc.’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:15 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-086264
U.S. dollars in millionsMobileyeOtherTotal
Revenues$498$10$508
Cost of revenues1741
Research and development, net1525
Sales and marketing54
General and administrative111
Segment performance$156$(1)$155
Amortization of intangible assets(114)
Share-based compensation(88)

Item 1. Financial Statements (Unaudited)

FAQ

What is Mobileye Global Inc.'s all other segments — research and development expense?
Mobileye Global Inc. (MBLY) reported all other segments — research and development expense of $5M in Q2 2026.
How has Mobileye Global Inc.'s all other segments — research and development expense changed year-over-year?
Mobileye Global Inc.'s all other segments — research and development expense decreased by 28.6% year-over-year, from $7M to $5M.
What is the long-term trend for Mobileye Global Inc.'s all other segments — research and development expense?
Over 3 years (2022 to 2025), Mobileye Global Inc.'s all other segments — research and development expense has grown at a -9.4% compound annual growth rate (CAGR), from $39M to $29M.
What does all other segments — research and development expense mean?
Captures the costs incurred for research and development activities specifically associated with secondary or non-core business segments. This includes investments in new technologies, product design, and testing aimed at future innovation within these specific areas. It reflects the company's commitment to long-term growth and technical advancement outside of its primary business focus.

Ask your AI about Mobileye Global Inc.'s all other segments — research and development expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude